Luke Jedynak is a Senior Associate (effective July 2020) in the firm’s corporate and commercial team. He works for a diverse range of commercial clients, including ASX 100 companies, private equity firms and large privately-held businesses.
Luke assists his clients on a diverse range of commercial matters, including initial public offerings on the ASX, large-scale mergers and acquisitions as well as smaller, strategic investments. Luke is known for his smart, commercial and outcomes-focused approach to transactions.
Luke joined Arnold Bloch Leibler in 2016 and was admitted to practice in 2017. He has undergraduate degrees in law and chemical engineering as well as a master of laws from the University of Melbourne.
Luke is currently undertaking a part-time MBA at the Melbourne Business School.
Recent transactions Luke has acted on include:
- Nufarm’s divestment of its Latin American business to Sumitomo Chemical for AUD$1.18 billion
- Representing the CEO and major shareholder of Australian based hydraulics manufacturer RYCO Hydraulics in relation to Italian based Manuli Rubber Industries’ acquisition of a majority shareholding in RYCO
- The merger of Apotex Australia and Arrow Pharmaceuticals to form Australia’s largest generic pharmaceuticals company, and
- Acting for the minority shareholders of Australian wagering company BetEasy in relation to the sale of their remaining interest in BetEasy to Canadian gaming company The Stars Group.